Total Payments
$17,127
2024 Payments
$231.63
Companies
21
Transactions
133
Medicare Patients
345
Medicare Billing
$27,829
Payment Breakdown by Category
Food & Beverage$11,371 (66.4%)
Consulting$4,995 (29.2%)
Travel$682.77 (4.0%)
Education$78.17 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,371 | 122 | 66.4% |
| Consulting Fee | $4,995 | 2 | 29.2% |
| Travel and Lodging | $682.77 | 2 | 4.0% |
| Education | $78.17 | 7 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $6,716 | 19 | $0 (2019) |
| Amgen Inc. | $1,777 | 20 | $0 (2023) |
| ABBVIE INC. | $1,424 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,179 | 13 | $0 (2021) |
| GENZYME CORPORATION | $720.86 | 7 | $0 (2023) |
| UCB, Inc. | $639.61 | 7 | $0 (2020) |
| PFIZER INC. | $601.04 | 9 | $0 (2018) |
| Horizon Pharma plc | $593.23 | 5 | $0 (2018) |
| Horizon Therapeutics plc | $498.80 | 4 | $0 (2022) |
| GlaxoSmithKline, LLC. | $450.84 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $231.63 | 2 | ABBVIE INC. ($123.07) |
| 2023 | $255.95 | 2 | GENZYME CORPORATION ($133.40) |
| 2022 | $323.10 | 3 | GENZYME CORPORATION ($208.17) |
| 2021 | $732.70 | 8 | Genentech, Inc. ($211.00) |
| 2020 | $623.73 | 7 | Horizon Therapeutics plc ($143.42) |
| 2019 | $8,258 | 35 | Celgene Corporation ($6,342) |
| 2018 | $2,933 | 31 | Amgen Inc. ($678.73) |
| 2017 | $3,769 | 45 | Novartis Pharmaceuticals Corporation ($655.12) |
All Payment Transactions
133 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $108.56 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 01/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $123.07 | General |
| Category: IMMUNOLOGY | ||||||
| 05/31/2023 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $122.55 | General |
| Category: Inflammation | ||||||
| 05/12/2023 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $133.40 | General |
| Category: Rheumatology | ||||||
| 09/08/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $114.93 | General |
| Category: KRYSTEXXA | ||||||
| 08/26/2022 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $128.77 | General |
| 04/08/2022 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $79.40 | General |
| 09/16/2021 | Genentech, Inc. | Actemra (Biological) | Food and Beverage | In-kind items and services | $112.61 | General |
| Category: Immunology | ||||||
| 08/24/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $125.54 | General |
| Category: KRYSTEXXA | ||||||
| 05/20/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $124.87 | General |
| Category: RESPIRATORY | ||||||
| 04/29/2021 | Genentech, Inc. | Actemra (Biological) | Food and Beverage | In-kind items and services | $98.39 | General |
| Category: Immunology | ||||||
| 03/04/2021 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $49.08 | General |
| Category: IMMUNOLOGY | ||||||
| 03/03/2021 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 02/26/2021 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $61.81 | General |
| Category: IMMUNOLOGY | ||||||
| 01/06/2021 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $35.40 | General |
| Category: IMMUNOLOGY | ||||||
| 07/30/2020 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Education | In-kind items and services | $8.89 | General |
| Category: IMMUNOLOGY | ||||||
| 03/04/2020 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $143.42 | General |
| Category: KRYSTEXXA | ||||||
| 03/03/2020 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $117.11 | General |
| Category: IMMUNOLOGY | ||||||
| 02/05/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $112.92 | General |
| Category: RESPIRATORY | ||||||
| 01/30/2020 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $90.17 | General |
| Category: Immunology | ||||||
| 01/22/2020 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $80.43 | General |
| Category: Immunology | ||||||
| 01/15/2020 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $70.79 | General |
| Category: Immunology | ||||||
| 12/10/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: DERMATOLOGY | ||||||
| 10/24/2019 | AbbVie, Inc. | Rinvoq (Biological) | Food and Beverage | In-kind items and services | $92.85 | General |
| Category: Immunology | ||||||
| 10/17/2019 | Celgene Corporation | Otezla (Drug) | Consulting Fee | Cash or cash equivalent | $2,220.00 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 59 | 70 | $10,047 | $3,574 |
| 2022 | 2 | 63 | 73 | $10,952 | $3,914 |
| 2021 | 2 | 78 | 81 | $12,541 | $5,309 |
| 2020 | 5 | 145 | 154 | $23,169 | $15,033 |
Total Patients
345
Total Services
378
Medicare Billing
$27,829
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 21 | 27 | $4,887 | $1,829 | 37.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 38 | 43 | $5,160 | $1,745 | 33.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 30 | 34 | $6,272 | $2,226 | 35.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 33 | 39 | $4,680 | $1,688 | 36.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 49 | 51 | $9,009 | $3,874 | 43.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 29 | 30 | $3,532 | $1,435 | 40.6% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 31 | 31 | $7,165 | $4,653 | 64.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 52 | 61 | $6,660 | $4,607 | 69.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 28 | 28 | $5,686 | $3,222 | 56.7% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 23 | 23 | $2,819 | $1,869 | 66.3% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 11 | 11 | $839.74 | $681.64 | 81.2% |
About Dr. Kenneth Calamia, MD
Dr. Kenneth Calamia, MD is a Rheumatology healthcare provider based in Belfast, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1073503868.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Calamia, MD has received a total of $17,127 in payments from pharmaceutical and medical device companies, with $231.63 received in 2024. These payments were reported across 133 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($11,371).
As a Medicare-enrolled provider, Calamia has provided services to 345 Medicare beneficiaries, totaling 378 services with total Medicare billing of $27,829. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Other Specialties Rheumatology
- Location Belfast, ME
- Active Since 10/24/2005
- Last Updated 09/14/2023
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1073503868
Products in Payments
- Otezla (Drug) $6,613
- COSENTYX (Biological) $1,179
- Enbrel (Biological) $876.46
- Actemra (Biological) $606.47
- XELJANZ (Drug) $601.04
- Humira (Biological) $570.15
- KEVZARA (Drug) $547.95
- KRYSTEXXA (Biological) $498.80
- BENLYSTA (Biological) $450.84
- Cimzia (Drug) $408.39
- KRYSTEXXA (Drug) $347.74
- TALTZ (Drug) $283.65
- SIMPONI ARIA (Biological) $281.53
- Rinvoq (Biological) $280.15
- Prolia (Biological) $268.66
- RAYOS (Drug) $245.49
- OFEV (Drug) $237.79
- KEVZARA (Biological) $223.57
- RINVOQ (Biological) $220.28
- EVENITY (Biological) $206.93
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.